Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chelsea Mayoh

Showing results (51-60 of 100) with videos related to

Pageof 10
Sort By:
Leukemia|January 23, 2025
Targeting LMO2-induced autocrine FLT3 signaling to overcome chemoresistance in early T-cell precursor acute lymphoblastic leukemiaCedric S Tremblay, Jesslyn Saw, Feng Yan, et al.
British Journal of Haematology|December 2, 2017
A risk score including microdeletions improves relapse prediction for standard and medium risk precursor B-cell acute lymphoblastic leukaemia in childrenRosemary Sutton, Nicola C Venn, Tamara Law, et al.
Haematologica|February 11, 2021
Methotrexate-related central neurotoxicity: clinical characteristics, risk factors and genome-wide association study in children treated for acute lymphoblastic leukemiaMarion K Mateos, Glenn M Marshall, Pasquale M Barbaro, et al.
Neuro-Oncology|February 12, 2025
High-throughput in vitro drug screening and in vivo studies identify fenretinide as a brain-penetrant DMG therapeuticDannielle H Upton, Jie Liu, Sandra M George, et al.
Oncotarget|June 19, 2016
CCI-007, a novel small molecule with cytotoxic activity against infant leukemia with MLL rearrangementsKlaartje Somers, Daria A Chudakova, Shiloh M C Middlemiss, et al.
British Journal of Cancer|September 18, 2018
Brief Report: Potent clinical and radiological response to larotrectinib in TRK fusion-driven high-grade gliomaDavid S Ziegler, Marie Wong, Chelsea Mayoh, et al.
Cold Spring Harbor Molecular Case Studies|November 4, 2020
Recurrent <i>SPECC1L-NTRK</i> fusions in pediatric sarcoma and brain tumorsDong-Anh Khuong-Quang, Lauren M Brown, Marie Wong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2019
OBI-3424, a Novel AKR1C3-Activated Prodrug, Exhibits Potent Efficacy against Preclinical Models of T-ALLKathryn Evans, JianXin Duan, Tara Pritchard, et al.
Haematologica|March 31, 2022
Acute central nervous system toxicity during treatment of pediatric acute lymphoblastic leukemia: phenotypes, risk factors and genotypesStavroula Anastasopoulou, Rikke Linnemann Nielsen, Bodil Als-Nielsen, et al.
Scientific Reports|March 7, 2023
Histone H3-wild type diffuse midline gliomas with H3K27me3 loss are a distinct entity with exclusive EGFR or ACVR1 mutation and differential methylation of homeobox genesPamela Ajuyah, Chelsea Mayoh, Loretta M S Lau, et al.
Pageof 10

Showing results (51-60 of 100) with videos related to

Sort By:
Pageof 10
Leukemia|January 23, 2025
Targeting LMO2-induced autocrine FLT3 signaling to overcome chemoresistance in early T-cell precursor acute lymphoblastic leukemiaCedric S Tremblay, Jesslyn Saw, Feng Yan, et al.
British Journal of Haematology|December 2, 2017
A risk score including microdeletions improves relapse prediction for standard and medium risk precursor B-cell acute lymphoblastic leukaemia in childrenRosemary Sutton, Nicola C Venn, Tamara Law, et al.
Haematologica|February 11, 2021
Methotrexate-related central neurotoxicity: clinical characteristics, risk factors and genome-wide association study in children treated for acute lymphoblastic leukemiaMarion K Mateos, Glenn M Marshall, Pasquale M Barbaro, et al.
Neuro-Oncology|February 12, 2025
High-throughput in vitro drug screening and in vivo studies identify fenretinide as a brain-penetrant DMG therapeuticDannielle H Upton, Jie Liu, Sandra M George, et al.
Oncotarget|June 19, 2016
CCI-007, a novel small molecule with cytotoxic activity against infant leukemia with MLL rearrangementsKlaartje Somers, Daria A Chudakova, Shiloh M C Middlemiss, et al.
British Journal of Cancer|September 18, 2018
Brief Report: Potent clinical and radiological response to larotrectinib in TRK fusion-driven high-grade gliomaDavid S Ziegler, Marie Wong, Chelsea Mayoh, et al.
Cold Spring Harbor Molecular Case Studies|November 4, 2020
Recurrent <i>SPECC1L-NTRK</i> fusions in pediatric sarcoma and brain tumorsDong-Anh Khuong-Quang, Lauren M Brown, Marie Wong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2019
OBI-3424, a Novel AKR1C3-Activated Prodrug, Exhibits Potent Efficacy against Preclinical Models of T-ALLKathryn Evans, JianXin Duan, Tara Pritchard, et al.
Haematologica|March 31, 2022
Acute central nervous system toxicity during treatment of pediatric acute lymphoblastic leukemia: phenotypes, risk factors and genotypesStavroula Anastasopoulou, Rikke Linnemann Nielsen, Bodil Als-Nielsen, et al.
Scientific Reports|March 7, 2023
Histone H3-wild type diffuse midline gliomas with H3K27me3 loss are a distinct entity with exclusive EGFR or ACVR1 mutation and differential methylation of homeobox genesPamela Ajuyah, Chelsea Mayoh, Loretta M S Lau, et al.
Pageof 10